Hua R. Tang

No. 22 Qi Xiang Tai Road
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Retraction Note to: A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-κB and TIMP3/MMP9 pathways in cervical cancer cells.

Retraction Note to: A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-κB and TIMP3/MMP9 pathways in cervical cancer cells.

Journal: Cell death & disease

Published: July 28, 2025

Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4.

Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4.

Journal: Communications biology

Published: March 13, 2024

Retraction Note: miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.

Retraction Note: miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.

Journal: British journal of cancer

Published: June 26, 2023

Retraction Note: miR-3928v is induced by HBx via NF-κB/ EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.

Retraction Note: miR-3928v is induced by HBx via NF-κB/ EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 27, 2022

CD301b+ macrophage: the new booster for activating bone regeneration in periodontitis treatment.

CD301b+ macrophage: the new booster for activating bone regeneration in periodontitis treatment.

Journal: International journal of oral science

Published: September 28, 2022

Corrigendum to "TCDD-induced antagonism of MEHP-mediated migration and invasion partly involves aryl hydrocarbon receptor in MCF7 breast cancer cells" [J. Hazard. Mater. 398 (2020) 122869].

Corrigendum to "TCDD-induced antagonism of MEHP-mediated migration and invasion partly involves aryl hydrocarbon receptor in MCF7 breast cancer cells" [J. Hazard. Mater. 398 (2020) 122869].

Journal: Journal of hazardous materials

Published: November 22, 2021

Negatively Charged Sulfur Quantum Dots for Treatment of Drug-Resistant Pathogenic Bacterial Infections.

Negatively Charged Sulfur Quantum Dots for Treatment of Drug-Resistant Pathogenic Bacterial Infections.

Journal: Nano letters

Published: November 09, 2021

Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129].

Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129].

Journal: EBioMedicine

Published: October 31, 2021

Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells.

Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells.

Journal: Journal of Cancer

Published: September 20, 2021

Author Correction: ICP4-induced miR-101 attenuates HSV-1 replication.

Author Correction: ICP4-induced miR-101 attenuates HSV-1 replication.

Journal: Scientific reports

Published: August 07, 2021

Retraction notice to "MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5" [Canc. Lett. 322 (2012) 148-158].

Retraction notice to "MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5" [Canc. Lett. 322 (2012) 148-158].

Journal: Cancer letters

Published: July 18, 2021

Retraction Note: A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX.

Retraction Note: A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX.

Journal: Oncogenesis

Published: July 16, 2021

Showing 1-12 of 109

Last Updated: 09/26/2026